Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 341,880 shares at $1.17 ($400K) on 2024-03-14, disclosed to the SEC on 2024-03-15.
Open-market purchase of $400k MAIA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.17 | 170,940 | $200K | 50.0% |
| 2 | $1.17 | 170,940 | $200K | 50.0% |
| Total | $1.17 avg | 341,880 | $400K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |